Innovations in Immunology

Advancing Targeted Treatments for Immune-Related Ailments

Navigating Challenges in Immune-Related Disorders

Autoimmune disorders impact 5% – 8% percent of the U.S. population. Immune related disorders encompasses autoimmune, allergic, infectious, cancerous, metabolic, neurodegenerative like Alzheimer’s, and cardiovascular disorders.

The immune system’s dual role, protecting and sometimes harming the body as in autoimmune disorders, poses a complex challenge in achieving the right modulation for therapeutic purposes. Immunology research holds promise for effective treatments, personalized medicine, and seeks to enhance the lives of those affected by immune-related disorders.

In advancing drug discovery and development, Aganitha utilizes Generative AI and ML to:

Comprehend disease heterogeneity

Identify therapeutic targets

Design and optimize therapeutic modalities

In silico evaluate drug efficacy

AI and ML Solutions: Navigating Challenges in Immune-related Disorders

Unleashing the power of AI and ML to tackle immunological disorders with targeted diagnosis and treatment strategies.

Complexity of Immunological Processes

Owing to the complex interactions between various cell types, signaling pathways, and molecular components, Computational models can simulate and analyze complex immunological processes, helping understand the dynamics of immune responses in health and disease.

Biomarker discovery

Due to the severity, organ involvement, and systemic manifestations of immune disorders, biomarker discovery is challenging. AI can be used to analyze large datasets to identify potential biomarkers, aiding diagnostic and prognostic efforts.

Drug discovery and Optimization

Current immune-modulatory drugs are broad-acting, non-disease-specific, and linked to side effects like infection and malignancy. In silico tools facilitate virtual screening, enable precision drug design, predict side effects, personalize treatment, and expedite drug development.

Varied Immunotherapy Responses

Due to varied immunotherapy responses across all patients, predicting and optimizing responses is a significant challenge. ML models analyze patient data to identify factors influencing outcomes, guiding the development of more effective strategies.

Managing Big Data

Due to the generation of diverse data types, integrating them becomes challenging. AI and ML tools can integrate multi-omics data, providing a holistic view of immune system function and dysfunction.

Personalized Medicine

Due to significant inter-individual variability, requiring personalized treatment, AI and ML models analyze patient data to identify patterns and predict responses, facilitating the development of tailored personalized medicine.

Advancing Research, Therapeutics, and BioPharma

Generative AI, LLMs, and ML techniques advance cancer research, therapeutic interventions, and development.

Biomarker Identification:

We seek to identify biomarkers representative of a specific diseased condition, of response to a particular therapy and those which are translatable between species.

Tools: Single-cell transcriptomics, Covarying neighborhood analyses (CNA), cell-cell communication analysis.

Deciphering Mechanism Of Action:

We aim to uncover shared characteristics in rare autoimmune disorders, pinpoint distinctive pathways for specific conditions, and explore how Immunoglobulin-based therapies can effectively counteract autoimmune disorders.

Tools: Differential gene analysis and Weighted gene co-expression network analysis (WGCNA).

Patient Stratification:

We seek to classify responder and nonresponder sub-populations to the therapy of interest, and stratify cohorts of patients for accurate treatment options in each group.

Tools: Transcriptomics, multi-omics analysis, enrichment analysis, and understanding cell-cell communication.

Clinical trial progression:

We aim to integrate the end to end analyses of mechanisms of action, patient stratification, identifying translatable biomarkers, and augment the progression of clinical trials from murine models to human subjects.

Tools: Single cell transcriptomics analysis pipeline, and differential gene expression analysis.

Optimizing treatment and dosage:

We optimize treatment by studying the effectiveness and dosages of a therapy for specific disease types or subtypes, including its broad-spectrum activity.

Tools: Multi-omics and pathway analysis, biomarker identification, in silico tools.

Dataset assessment for the risk analysis:

We rigorously assess multi-omics data quality, considering key risk factors such as sample types, disease classification, patient metadata, dosage concentrations, post-treatment time, and sequencing platform.

Tools: Packages based on R or Python for in-depth analysis and quality control.

Discover our offerings across the biopharma value chain

Learn more about our platform, solutions, and services